Skip to main content
Caplight Logo









Shenzhen MagicRNA Biotechnology Co., Ltd.

Shenzhen MagicRNA Biotechnology Co., Ltd.

Private
ShenzhenHealthcare & Life Scienceshttps://magicrna.com/

Last Round

VC Round

Aug 29, 2025

Total Funding Raised

$1.54M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Shenzhen MagicRNA Biotechnology Co., Ltd. is a biotechnology company that develops mRNA drugs and lipid nanoparticle (LNP) delivery technologies for the treatment of autoimmune diseases and tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

lipid nanoparticleLNPmRNA therapeuticsin vivo cell reprogrammingextrahepatic deliveryCAR-T therapydrug delivery platformionizable lipidsmRNA synthesisLNP encapsulationnucleic acid deliverynon-viral deliverybiotech CDMOin vivo CAR-TRNA medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shenzhen MagicRNA Biotechnology Co., Ltd. Comparables

Compare Shenzhen MagicRNA Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Shenzhen MagicRNA Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Byterna Therapeutics
87%
Liberate Bio
86%
RinuaGene Biotechnology
84%

Shenzhen MagicRNA Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 29, 2025
VC RoundJan 16, 2024
AngelJan 3, 2023
AngelApr 20, 2022

Shenzhen MagicRNA Biotechnology Co., Ltd. Investors

Notable investors and investment history

Shenzhen MagicRNA Biotechnology Co., Ltd. investors
InvestorRounds
Shenzhen Credit Guarantee GroupAngel
IDG CapitalVC Round
海愿资本Angel, VC Round
YuanBio Venture CapitalVC Round
高瓴创投VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 25, 2026

    Monthly visitors grew 661% MoM.

  • Aug 29, 2025

    $14M round led by IDG Capital.

Shenzhen MagicRNA Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shenzhen MagicRNA Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shenzhen MagicRNA Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range4
Year Founded2021
Last FundingAug 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?